TGF-alpha, human recombinant protein
Transforming Growth Factor-α, Sacroma growth factor, TGF-type I, ETGF
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P01135 |
|---|---|
| Calculated MW | 5.5 kDa |
| Gene ID | 7039 |
|---|---|
| Gene Symbol | TGFA |
| Other Names | Transforming Growth Factor-α, Sacroma growth factor, TGF-type I, ETGF |
| Gene Source | Human |
| Source | E. coli |
| Assay&Purity | SDS-PAGE; ≥98% |
| Assay2&Purity2 | HPLC; ≥98% |
| Recombinant | Yes |
| Results | <0.2 ng/ml |
| Target/Specificity | TGF-alpha |
| Application Notes | Reconstitute in H₂O to a concentration of 0.1-1.0 mg/ml. The solution can then be diluted into other aqueous buffers and store at 4°C for 1 week or –20°C for future use. For most in vitro applications, TGF-α exerts its biological activity in the concentration range of 0.5 to 25 ng/ml. |
| Format | Lyophilized protein |
| Storage | -20°C; Sterile filtered and lyophilized with no additives |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Transforming Growth Factor-α (TGF-α) stimulates the proliferation of a wide range of epidermal and epithelial cells. TGF-α has been shown to play a role in the autocrine growth of certain transformed cells. Human TGF-α is a 5.5 kDa protein containing 50 amino acid residues.
References
Derynck R.,et al.Cell 38:287-297(1984).
Jakowlew S.B.,et al.Mol. Endocrinol. 2:1056-1063(1988).
Qian J.F.,et al.Gene 132:291-296(1993).
Qian J.F.,et al.Am. J. Hum. Genet. 53:168-175(1993).
Machida J.,et al.Genomics 61:237-242(1999).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.

